The American Chemical Society (ACS) ended 2021 with solid financial results. The Society generated a record change in net assets without donor restrictions from operations of $80.5 million on revenues of $685.6 million and expenses of $605.1 million. This performance was driven by strong revenues from the information services divisions along with lower expenses that resulted from the ongoing impacts of the COVID-19 pandemic.
The Society’s overall financial position improved, with net assets without donor restrictions increasing by $127.8 million from Dec. 31, 2020, to reach $716.5 million as of Dec. 31, 2021. The year-end balance includes the aforementioned $80.5 million net from operations, along with investment and foreign exchange gains of $61.1 million. The Society ended the year in compliance with all of the ACS Board-established financial guidelines.
The audited financial statements and additional finance-related resources can be accessed on the Society’s financial information website.
ACS is grateful for the generous support provided by donors and sponsors for its programs and awards. To see the names of those who contributed to ACS national awards, please view the list of 2021 sponsors.